Get the Stockscreener App
15.03
1.44%
-0.22
Novavax, Inc. Stock (NVAX) Forecast
The Novavax, Inc. (NVAX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $3.203, representing a -78.69% decrease from the current price of $15.03. The highest analyst price target is $4.1744, and the lowest is $2.2316.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NVAX Price Target
Average 22.98
(+52.90% Upside)
Is Novavax, Inc. (NVAX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 74.08 | Sell |
| STOCH(9,6) | 61.81 | Neutral |
| STOCHRSI(14) | 2.2314 | Buy |
| MACD(12,26) | 2.6483 | Buy |
| ADX(14) | 50.43 | Buy |
| William %R | -30.08 | Neutral |
| CCI(14) | 33.02 | Neutral |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
15.00
Buy
|
14.43
Buy
|
| MA20 |
11.80
Buy
|
12.38
Buy
|
| MA50 |
7.3425
Buy
|
8.9796
Buy
|
| MA100 |
5.9623
Buy
|
7.2934
Buy
|
| MA200 |
6.3013
Buy
|
6.8259
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, NVAX could be considered a Strong Buy, with 17 technical analysis indicators signaling 13 Buy signals, 1 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on NVAX, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 74.08 indicates that NVAX is overbought. This suggests that NVAX price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 61.81 indicates that NVAX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 2.2314 indicates that NVAX is oversold. This suggests that NVAX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 50.43 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 33.02 indicates that NVAX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term NVAX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Novavax, Inc. financial reports and earnings history, Novavax, Inc. (NVAX) stock could reach $4.1836 by 2030, $5.3488 by 2040 and $83.18 by 2050. See the projected annual prices until 2050 of the Novavax, Inc. stock below:
- Novavax, Inc. (NVAX) is expected to reach an average price of $2.8087 in 2035, with a high prediction of $4.7215 and a low estimate of $2.5387. This indicates an $-81.31% rise from the last recorded price of $15.03.
- Novavax, Inc. (NVAX) stock is projected to chart a bullish course in 2040, with an average price target of $3.3442, representing an $-77.75% surge from its current level. The forecast ranges from a conservative $2.508 to a sky-high $5.3488.
- Our analysts predict Novavax, Inc. (NVAX) to jump -31.51% by 2045, soaring from $10.22 to an average price of $10.29, potentially reaching $27.34. While $10.22 is the low estimate, the potential upside is significant.
- Novavax, Inc. (NVAX) stock is expected to climb by 2050, reaching an average of $74.50, a $395.65% jump from its current level. However, a wide range of estimates exists, with high and low targets of $83.18 and $58.01, respectively, highlighting the market's uncertainty.
Novavax, Inc. Stock (NVAX) Year by Year Forecast
Novavax, Inc. Stock (NVAX) Price Forecast for 2024
Our forecast for NVAX stock price in 2024 now indicates an average price target of $4.7379 with a high forecast of $7.74 and a low forecast of $1.7359. The average prediction reflects an decrease of -68.48% from the last recorded price of $15.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2024 | $2.5016 | $2.2316 | $4.1744 | -83.36% |
| August, 2024 | $4.3788 | $2.1918 | $6.3188 | -70.87% |
| September, 2024 | $4.726 | $3.4024 | $5.826 | -68.56% |
| October, 2024 | $2.6851 | $2.5651 | $4.8078 | -82.14% |
| November, 2024 | $2.8023 | $2.2887 | $3.0423 | -81.36% |
| December, 2024 | $2.5545 | $1.7359 | $3.8395 | -83.00% |
Novavax, Inc. Stock (NVAX) Price Forecast for 2025
Novavax, Inc. Stock (NVAX) is expected to reach an average price of $94.77 in 2025, with a high prediction of $187.67 and a low estimate of $1.8639. This indicates an +530.52% rise from the last recorded price of $15.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $2.6235 | $2.0531 | $2.8085 | -82.55% |
| February, 2025 | $5.7257 | $1.8639 | $8.1539 | -61.90% |
| March, 2025 | $13.86 | $4.7675 | $15.92 | -7.80% |
| April, 2025 | $11.57 | $4.9983 | $13.16 | -23.01% |
| May, 2025 | $22.03 | $11.45 | $24.57 | +46.56% |
| June, 2025 | $41.88 | $14.65 | $44.23 | +178.62% |
| July, 2025 | $63.17 | $38.75 | $64.32 | +320.26% |
| August, 2025 | $92.62 | $57.56 | $110.03 | +516.25% |
| September, 2025 | $168.56 | $93.52 | $187.67 | +1,021% |
| October, 2025 | $91.21 | $84.94 | $179.97 | +506.84% |
| November, 2025 | $106.64 | $81.50 | $124.82 | +609.49% |
| December, 2025 | $79.00 | $76.79 | $120.21 | +425.65% |
Novavax, Inc. Stock (NVAX) Price Forecast for 2026
The predicted value for Novavax, Inc. (NVAX) in 2026 is set at an average of $202.45. Estimates vary from a peak of $330.00 to a trough of $74.89, indicating an +1,247% surge from the present price of $15.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $123.99 | $74.89 | $130.30 | +724.96% |
| February, 2026 | $123.11 | $104.42 | $148.81 | +719.09% |
| March, 2026 | $125.75 | $105.39 | $135.89 | +736.64% |
| April, 2026 | $276.21 | $119.58 | $330.00 | +1,738% |
| May, 2026 | $226.58 | $145.72 | $275.48 | +1,408% |
| June, 2026 | $178.08 | $157.42 | $239.81 | +1,085% |
| July, 2026 | $130.04 | $115.47 | $262.02 | +765.20% |
| August, 2026 | $208.04 | $126.93 | $212.86 | +1,284% |
| September, 2026 | $186.96 | $167.16 | $227.86 | +1,144% |
| October, 2026 | $188.25 | $170.38 | $245.02 | +1,153% |
| November, 2026 | $236.92 | $190.37 | $258.37 | +1,476% |
| December, 2026 | $205.44 | $196.39 | $276.18 | +1,267% |
Novavax, Inc. Stock (NVAX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Novavax, Inc. (NVAX) is $134.13, with a high forecast of $234.91 and a low forecast of $33.35. This indicates an +792.42% increase from the last price of $15.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $132.98 | $119.75 | $190.79 | +784.74% |
| February, 2027 | $190.74 | $128.48 | $199.88 | +1,169% |
| March, 2027 | $215.73 | $136.66 | $227.41 | +1,335% |
| April, 2027 | $109.24 | $99.52 | $234.91 | +626.81% |
| May, 2027 | $87.76 | $64.80 | $105.95 | +483.88% |
| June, 2027 | $70.16 | $67.93 | $99.82 | +366.77% |
| July, 2027 | $72.09 | $64.26 | $84.04 | +379.66% |
| August, 2027 | $45.10 | $44.48 | $76.10 | +200.07% |
| September, 2027 | $53.75 | $39.79 | $61.68 | +257.61% |
| October, 2027 | $38.71 | $33.35 | $55.95 | +157.53% |
| November, 2027 | $74.59 | $37.85 | $75.24 | +396.30% |
| December, 2027 | $39.95 | $36.64 | $73.81 | +165.82% |
Novavax, Inc. Stock (NVAX) Price Forecast for 2028
In 2028, Novavax, Inc. (NVAX) is projected to reach an average price of $23.33, with a high projection of $42.50 and a low estimate of $4.1541. This indicates an +55.22% rise from the last price of $15.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $28.88 | $28.81 | $42.50 | +92.15% |
| February, 2028 | $16.70 | $16.35 | $31.86 | +11.09% |
| March, 2028 | $20.78 | $14.50 | $23.15 | +38.23% |
| April, 2028 | $15.05 | $14.83 | $24.17 | +0.15% |
| May, 2028 | $8.182 | $7.8802 | $17.07 | -45.56% |
| June, 2028 | $10.08 | $7.2738 | $12.23 | -32.94% |
| July, 2028 | $8.4164 | $8.0164 | $11.18 | -44.00% |
| August, 2028 | $5.0655 | $4.7955 | $8.8183 | -66.30% |
| September, 2028 | $7.0127 | $4.1541 | $7.5027 | -53.34% |
| October, 2028 | $6.2699 | $5.4499 | $8.2363 | -58.28% |
| November, 2028 | $6.1889 | $5.2053 | $9.9217 | -58.82% |
| December, 2028 | $6.0061 | $5.1361 | $7.0975 | -60.04% |
Novavax, Inc. Stock (NVAX) Price Forecast for 2029
The 2029 price forecast for Novavax, Inc. Stock (NVAX) is $5.5239 on average, with a high prediction of $8.8977 and a low estimate of $2.15. This represents an -63.25% decrease from the previous price of $15.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $7.8651 | $5.4779 | $8.7597 | -47.67% |
| February, 2029 | $6.6423 | $5.4337 | $8.1923 | -55.81% |
| March, 2029 | $6.3095 | $5.8995 | $8.8977 | -58.02% |
| April, 2029 | $5.6567 | $5.3253 | $6.7549 | -62.36% |
| May, 2029 | $4.8557 | $4.5657 | $6.1057 | -67.69% |
| June, 2029 | $4.1929 | $3.9193 | $5.1275 | -72.10% |
| July, 2029 | $3.4302 | $3.4302 | $4.6747 | -77.18% |
| August, 2029 | $2.6392 | $2.5892 | $3.972 | -82.44% |
| September, 2029 | $3.9364 | $2.1752 | $4.1064 | -73.81% |
| October, 2029 | $3.3554 | $2.8782 | $4.6982 | -77.68% |
| November, 2029 | $2.6326 | $2.4726 | $3.6072 | -82.48% |
| December, 2029 | $2.81 | $2.15 | $5.88 | -81.30% |
Novavax, Inc. Stock (NVAX) Price Forecast for 2030
Novavax, Inc. Stock (NVAX) is expected to reach an average price of $7.107 in 2030, with a high forecast of $14.15 and a low forecast of $0.0683. This signifies an -52.71% decrease from the last price of $15.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.313 | $0.9481 | $4.1836 | -91.26% |
| February, 2030 | $1.3024 | $1.1524 | $3.4552 | -91.33% |
| March, 2030 | $0.6559 | $0.3932 | $1.216 | -95.64% |
| April, 2030 | $2.2613 | $0.3589 | $4.4877 | -84.95% |
| May, 2030 | $1.4393 | $1.3593 | $4.0021 | -90.42% |
| June, 2030 | $0.8237 | $0.5437 | $1.5129 | -94.52% |
| July, 2030 | $0.1317 | $0.0683 | $1.2345 | -99.12% |
| August, 2030 | $0.4242 | $0.0953 | $2.0389 | -97.18% |
| September, 2030 | $0.3556 | $0.2777 | $1.1406 | -97.63% |
| October, 2030 | $4.0786 | $0.076 | $6.3678 | -72.86% |
| November, 2030 | $4.753 | $3.7622 | $14.15 | -68.38% |
| December, 2030 | $11.80 | $3.2266 | $12.03 | -21.51% |
0.79%
3.50%
Cap:
|
Volume (24h):